Product Overview
[Drug Name]
Generic Name: Irbesartan Dispersible Tablets
Trade Name: Irbesartan Dispersible Tablets 0.075g x 30 Tablets
[Main Ingredient]
The main ingredient of this product is irbesartan.
[Appearance]
This product is white or off-white tablets.
[Indications/Main Functions]
Treatment of essential hypertension. Treatment of diabetic nephropathy with hypertension.
[Specifications]
0.075g x 30 tablets
[Dosage and Administration]
The recommended initial and maintenance dose is 0.15g daily. Dietary considerations have no effect on medication administration. Generally, 0.15g of irbesartan once daily provides better 24-hour blood pressure control than 75mg. However, for certain patients, particularly those undergoing hemodialysis and those over 75 years of age, a 75mg initial dose may be considered. For patients whose blood pressure is not effectively controlled with 0.15g of irbesartan once daily, the dose may be increased to 0.30g or other antihypertensive medications may be added. In particular, the addition of hydrochlorothiazide diuretics has been shown to have additive effects. In hypertensive patients with type 2 diabetes, the initial treatment dose should be 0.15g once daily, which can be increased to 0.30g once daily as a maintenance dose for renal disease. Treatment of hypertensive patients with type 2 diabetes with this drug has shown renal benefits. These results are based on studies requiring this drug to be used in combination with other antihypertensive medications to achieve target blood pressure. Renal Impairment: No dose adjustment is required for patients with renal impairment, but a lower initial dose may be considered for patients undergoing hemodialysis. Volume Depletion: Patients with volume and/or sodium depletion should have their volume and/or sodium depletion corrected before using this drug. Hepatic Impairment: No dose adjustment is required for patients with mild to moderate hepatic impairment. There is currently no clinical experience in patients with severe hepatic impairment.
[Adverse Reactions]
Not yet known.
[Contraindications]
Contraindicated in breastfeeding women.
[Drug Interactions]
Drug interactions may occur if used concurrently with other medications. Consult your physician or pharmacist for details.
[Precautions]
Not yet known.
[Pediatric Use]
Not yet known.
[Elderly Use]
Not yet known.
[Overdose]
Not yet known.
[Pharmacology and Toxicology]
Not yet known.
